AUG 19, 2020 11:00 AM PDT

Del Diseño a la Implementación de Pruebas Diagnósticas SARS-CoV-2

Speakers

Abstract

FECHA: 19 de Agosto, 2020

HORA: 10:00 AM PST 1:00 PM CST

 

Desde que se detectó por primera vez en Wuhan, China, en 2019, el nuevo coronavirus SARS-CoV-2 y la enfermedad que causa, COVID-19, se han propagado rápidamente por todo el mundo. La disminución de la propagación de la enfermedad se basa en medidas de distanciamiento social, así como en pruebas diagnósticas generalizadas y rápidas. Este seminario web discutirá el diseño y desarrollo del ensayo de diagnóstico SARS CoV-2, así como revisar diferentes estrategias sobre la implementación de pruebas moleculares SARS-CoV-2 bajo la Autorización de Uso de Emergencia de la FDA solamente (EUA) en una Red Integrada de Entrega hospitalaria (IDN) de los Estados Unidos.

 

Objetivos de Aprendizaje:

  • Comprender las características importantes del ensayo a tener en cuenta durante el diseño y desarrollo del ensayo SARS CoV-2
  • Revisar los desafíos y los éxitos durante la implementación y amplíe las pruebas SARS-CoV-2
  • Evaluar diferentes aplicaciones de los resultados de la PCR SARS-CoV-2 para comprender el estado y la progresión de la enfermedad

 

 

Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
Loading Comments...
Show Resources